サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1634177

眼科用パッケージングの世界市場 - 2025～2033年

Global Ophthalmology Packaging Market - 2025 - 2033

出版日
ページ情報
英文 176 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
眼科用パッケージングの世界市場 - 2025～2033年
出版日: 2025年01月13日
発行: DataM Intelligence
ページ情報: 英文 176 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

眼科用パッケージングの世界市場は2024年に125億米ドルに達し、2033年には278億米ドルに達すると予測され、予測期間2025年のCAGRは9.7%で成長します。

眼科用パッケージングは、医薬品、医療機器、手術器具などのアイケア製品向けに設計された特殊なパッケージングソリューションを指します。この分野には、ライフサイクルを通じて眼科製品の安全性、無菌性、完全性を保証するパッケージング材料の設計、製造、流通が含まれます。眼科用パッケージングの主な目的は、眼科用医薬品や器具の無菌性を保護することです。多くの眼科処方製品は局所的または眼内に投与されるため、汚染された場合、感染症や有害な反応など、健康上の重大な危険につながる可能性があります。

眼科用パッケージングに対する需要の増加は、予測期間中の市場を牽引する要因です。眼疾患の増加に伴い、点眼薬の需要も増加し、眼科用パッケージングの需要も増加します。例えば、米国国立衛生研究所（National Institute of Health）によると、世界中で2億人がAMDに罹患していると推定されており、2040年までにこの数は3億人近くにまで増加すると予測されています。2050年までには、540万人のアメリカ人がこのようなパターンになると予想されています。

市場力学：

促進要因と阻害要因

眼科用パッケージング需要の増加

眼科用パッケージングに対する需要の増加は、世界の眼科市場の成長において重要な要因となることが予想されます。この成長は、眼疾患の有病率の増加、薬物送達技術の進歩、eコマースの増加、防腐剤フリー製剤へのシフト、最近の製品の発売や承認など、多くの要因によってもたらされます。

緑内障、白内障、加齢黄斑変性など様々な眼疾患を患う人が増えるにつれ、製品の完全性と患者の安全を守る効果的で安全なパッケージング・ソリューションに対する需要も高まっています。例えば、緑内障研究財団によると、緑内障は世界で推定8,000万人が罹患しています。最も興味深いことに、緑内障患者の半数以上が自分の症状に気づいていません。300万人以上のアメリカ人が緑内障を患っているが、その半数以上が自分の症状に気づいていません。長生きすればするほど、緑内障を発症する可能性は高くなります。原発開放隅角緑内障は、2010年には世界中で840万人が失明したと考えられています。2040年までに、2,200万人が緑内障で失明すると予測されています。

さらに、スマートパッケージング技術の先進は、眼科用パッケージの様相を一変させました。RFIDとQRコードの統合は、トレーサビリティと安全性を向上させ、流通過程を通じて製品の状態をより正確に監視することを可能にします。これらの技術は、患者の服薬アドヒアランスを向上させるだけでなく、医薬品サプライチェーンにおける透明性と責任に対する規制上の要求の高まりにも合致しています。

eコマースの開発も、眼科用パッケージの増加を促進する重要な要素です。より多くの人々が眼科治療のためにオンライン薬局を利用するようになり、安全で改ざん防止、漏れのないパッケージソリューションが急務となっています。メーカー各社はこの傾向に対応し、消費者への直接配送の厳しい動向に耐え、かつ配送後の製品の安全性と機能性を保証するカスタマイズされたパッケージを考案しています。

高い生産コスト

生産コストの高さなどの要因が、世界の眼科用パッケージング市場の妨げになると予想されます。製品の安全性と有効性を保証するために、眼科用パッケージングメーカーは革新的な材料と技術を使用しなければなりません。このような厳しい品質基準は高い製造コストにつながることが多く、複雑な製造工程に従事する資金力のない中小企業にとっては特に困難なことです。その結果、高い製造コストは市場参入と競争力を制限し、業界全体の成長と革新を妨げる可能性があります。眼科用パッケージの平均製造コストは、パッケージデザインの複雑さや使用する材料によって異なりますが、1個当たり0.05～0.50ドルと推定されます。例えば、単純なプラスチックのスポイトボトルはこの中では低い方かもしれませんが、スマート技術や専門的な材料を使用したより高度なデザインはより高価になる可能性があります。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 影響要因
    • 促進要因
      • 眼科用パッケージング需要の増加
    • 抑制要因
      • 高い生産コスト
    • 機会
    • 影響分析

第5章 産業分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 価格分析
  • 規制分析
  • 償還分析
  • 特許分析
  • SWOT分析
  • DMIの見解

第6章 パッケージングタイプ別

  • チューブ
  • ボトル
  • 注射器
  • フレキシブルポーチ
  • アンプル
  • バイアル

第7章 用途別

  • 目薬
  • 眼科用ジェル
  • 眼科用軟膏
  • 抗VEGF薬

第8章 適応症別

  • 屈折異常
  • 白内障と緑内障
  • 網膜疾患
  • 角膜疾患
  • 小児眼科
  • その他

第9章 投与量別

  • マルチ投与
  • 単回投与

第10章 素材別

  • ガラス
  • プラスチック
  • その他

第11章 エンドユーザー別

  • 製薬会社
  • 医療機器メーカー
  • ヘルスケア提供者

第12章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他欧州地域
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • 中東・アフリカ

第13章 競合情勢

  • 競合シナリオ
  • 市況・シェア分析
  • M&A分析

第14章 企業プロファイル

  • Amcor plc
    • 会社概要
    • 製品ポートフォリオと概要
    • 財務概要
    • 主な発展
  • West Pharmaceutical Services, Inc.
  • Gerresheimer AG
  • Schott AG
  • AptarGroup, Inc.
  • Johnson & Johnson Services, Inc.
  • Bausch+Lomb
  • Aerie Pharmaceuticals, Inc.
  • Merck & Co., Inc.
  • Akorn Operating Company LLC

第15章 付録

目次
Product Code: MD8991

The global ophthalmology packaging market reached US$ 12.5 billion in 2024 and is expected to reach US$ 27.8 billion by 2033, growing at a CAGR of 9.7% during the forecast period 2025-2033.

Ophthalmology packaging refers to specialized packaging solutions designed for eye care products such as medications, medical devices, and surgical instruments. This field includes the design, manufacture, and distribution of packaging materials that assure the safety, sterility, and integrity of ophthalmic products throughout their life cycle. The major purpose of ophthalmic packaging is to protect the sterility of eye drugs and devices. Because many ophthalmic prescription products are delivered topically or intraocularly, any contamination might result in major health hazards, including infections and harmful reactions.

The increasing demand for ophthalmology packaging is the driving factor that drives the market over the forecast period. As the number of ocular disorders increases, the demand for the eye drops increases and the demand for the ophthalmology packaging also increases. For instance, according to the National Institute of Health, 200 million people worldwide are estimated to have AMD, and by 2040, this number is projected to rise to close to 300 million. By 2050, 5.4 million Americans are anticipated to be affected by rising patterns similar to this one.

Market Dynamics: Drivers & Restraints

Increasing demand for ophthalmology packaging

The increasing demand for ophthalmology packaging is expected to be a significant factor in the growth of the global ophthalmology market. This growth is driven by a number of factors, including an increase in the prevalence of eye diseases, advances in medication delivery technologies, increase in the e-commerce and a shift toward preservative-free formulation, recent product launches and approvals.

As the number of people suffering from various eye disorders including glaucoma, cataracts, and age-related macular degeneration grows, so does the demand for effective and safe packaging solutions that protect product integrity and patient safety. For instance, aaccording to the Glaucoma Research Foundation, glaucoma affects an estimated 80 million individuals globally. Most interestingly, over half of all glaucoma patients are unaware of their condition. More than 3 million Americans suffer from glaucoma, and over half of them are unaware of their condition. The longer someone lives, the more likely they are to develop glaucoma. Primary open-angle glaucoma is believed to have blinded 8.4 million people around the world in 2010. By 2040, it is anticipated that 22 million people will be blind due to glaucoma.

Furthermore, advances in smart packaging technologies have transformed the face of ophthalmic packaging. RFID and QR code integration improve traceability and safety, enabling for more accurate monitoring of product conditions throughout the distribution process. These technologies not only increase patient adherence to drug regimens, but they also align with rising regulatory demands for transparency and responsibility in pharmaceutical supply chains.

The development of e-commerce is another important element driving the increase of ophthalmic packaging. As more people turn to online pharmacies for eye care, there is an urgent need for secure, tamper-evident, and leak-proof packaging solutions. Manufacturers are responding to this trend by inventing customized packaging that can resist the rigors of direct-to-consumer shipping while guaranteeing that products stay safe and functional once delivered.

High production costs

Factors such as high production costs are expected to hamper the global ophthalmology packaging market. To assure product safety and efficacy, ophthalmic packaging manufacturers must use innovative materials and technology. These severe quality criteria frequently result in higher production costs, which can be especially difficult for smaller businesses who lack the financial resources to engage in complex manufacturing procedures. As a result, high production costs might limit market access and competitiveness, impeding overall growth and innovation in the industry. The average manufacturing costs for ophthalmic packaging are estimated to range between $0.05 and $0.50 per unit, depending on the complexity of the package design and materials utilized. Simple plastic dropper bottles, for example, may be on the lower end of this spectrum, but more advanced designs that use smart technology or specialist materials may be more expensive.

Segment Analysis

The global ophthalmology packaging market is segmented based on packaging type, application, indication, dosage, material, end-user, and region.

Eye Drops segment is expected to dominate the global ophthalmology packaging market share

Several compelling factors are anticipated to drive the global ophthalmology packaging market, with eye drops leading among them such as increasing prevalence of ocular disorders, recent product launches and approvals and technological advancements. As one of the most regularly used types of medication for a variety of eye problems, eye drops necessitate specific packaging solutions that assure sterility, ease of use, and precise dosing. The rising prevalence of eye illnesses such as glaucoma, dry eye syndrome, and allergies has fueled demand for effective treatments, resulting in an increase in ophthalmic product manufacture and distribution, notably eye drops. This trend is prominent in the significant market share for this sector, which is expected remain consistent as healthcare practitioners and patients rely more on these formulations to manage eye health.

For instance, according to the World Health Organization, cataracts affect approximately 65.2 million people and cause moderate to severe vision loss in over 80% cases. Cataract is responsible for over 51% of blindness in the Eastern Mediterranean Region. Moreover, according to the UH Hospitals, an estimated 3.2 million women age 50 and over, and 1.68 million men age 50 and over are affected by dry eye. The occurrence of dry eye increases with age. SERI reports that nearly 75 percent of people over age 65 will experience dry eye syndrome6, and the condition occurs most often in older women after menopause. As the number of ocular disorders increases, the demand for the eye drops increases and the demand for the ophthalmology packaging also increases.

Furthermore, innovations in packaging technology are helping to drive the expansion of this market. Consumers concerned with safety and efficacy are increasingly turning to innovations like preservative-free formulations and user-friendly delivery technologies. These advancements not only improve patient compliance, but also reflect emerging trends toward environmentally responsible packaging alternatives. As manufacturers invest in R&D to develop smarter and more sustainable packaging alternatives, the eye drops segment will continue to capitalize on improved product offerings that fulfills evolving demands from customers. For instance, in November 2024, Berry Global launched a new 'easy-squeeze' ophthalmic 10ml bottle that has been approved for use with Aptar Pharma's Ophthalmic Squeeze Dispenser (OSD), a solution for preservative-free product such as eye treatments.

Geographical Analysis

North America is expected to hold a significant position in the global ophthalmology packaging market share

The dominance of the North American market in the global ophthalmology packaging market is due to various factors such as advanced healthcare infrastructure, robust healthcare infrastructure, technological advancements, high prevalence of ocular diseases, strategic partnerships, increasing export of ophthalmic products, product launches and approvals, and increasing adoption of innovative medical technologies.

The increasing prevalence of ocular disorders in this region increases the demand for ophthalmology packaging. For instance, according to Dry Eye Directory, currently between 16.7 million and 50.2 million Americans have dry eyes. This is between 5-15% of the population. Dry Eye Disease in the USA costs over $55.4 billion to the economy each year. A large population study of over 79,866 people in Netherlands found that 9.1% had dry eye disease. Moreover, according to the Centers for Disease Control and Prevention, an estimated 9.6 million people in the United States were living with diabetic retinopathy. There were 8.94 million people aged >=40 years with DR and 1.71 million people aged >=40 years with vision threatening DR. The prevalence rate was higher among males than females for DR (0.64% vs. 0.47%) and vision-threatening DR (2.74% vs 1.94%). As the number of ocular disorders increases, the demand for the ophthalmology packaging increases and the demand for the ophthalmology packaging also increases.

Furthermore, the increased export of ophthalmic products from North America contributes significantly to the region's market share growth. As North American organizations create innovative packaging solutions that match international requirements, they will be better positioned to take a larger share of the worldwide market. The emergence of internet shopping creates new prospects for growth, as customers seek easy access to eye care products via e-commerce platforms. This transition needs safe and economical packaging solutions that can resist shipping and handling while preserving product integrity.

Asia Pacific is growing at the fastest pace in the global ophthalmology packaging market

The Asia Pacific region is emerging as the fastest-growing market for ophthalmology packaging, owing to a combination of demographic trends, increased healthcare investment, recent launches, and an increasing prevalence of ocular diseases.

The increasing prevalence of ocular diseases is one of the factors that drive the market in this region. For instance, according to the National Institute of Health, according to a survey, India has an unmet need of more than 22 million blind eyes (12 million blind persons), with cataracts accounting for 80.1% of these cases. The annual incidence of cataract blindness is around 3.8 million. The current annual level of performance is approximately 1.6-1.9 million cataract surgeries. To clear the holdup of cataract cases and address the rising incidence, 5-6 million cataract procedures will be conducted yearly, rising to the current rate of 1.7 million per year.

One of the key drivers of this growth has been the rise of the pharmaceutical manufacturing sector in Asia-Pacific countries. Countries such as China and India are emerging as major players in the global pharmaceutical scenario, because of huge investments in healthcare infrastructure and manufacturing skills. The increased manufacturing of ophthalmic products, combined with a greater emphasis on innovative packaging technologies, is expected to fulfill the growing need for eye care solutions. For instance, adding smart packaging features like tamper-evident seals and user-friendly dispensing systems improves patient compliance and safety, making these items more desirable to consumers.

Competitive Landscape

The major global players in the global ophthalmology packaging market include Amcor plc, West Pharmaceutical Services, Inc., Gerresheimer AG, Schott AG, AptarGroup, Inc., Johnson & Johnson Services, Inc., Bausch + Lomb, Aerie Pharmaceuticals, Inc., Merck & Co., Inc., Akorn Operating Company LLC among others.

Emerging Players

Dou Yee Enterprises, Schott AG, and Bormio Pharma among others

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global ophthalmology packaging market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Packaging Type
  • 3.2. Snippet by Application
  • 3.3. Snippet by Indication
  • 3.4. Snippet by Dosage
  • 3.5. Snippet by Material
  • 3.6. Snippet by End-User
  • 3.7. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
    • 4.1.2. Increasing Demand for Ophthalmology Packaging
    • 4.1.3. Restraints
    • 4.1.4. High Production Costs
    • 4.1.5. Opportunity
    • 4.1.6. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Reimbursement Analysis
  • 5.6. Patent Analysis
  • 5.7. SWOT Analysis
  • 5.8. DMI Opinion

6. By Packaging Type

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Packaging Type
    • 6.1.2. Market Attractiveness Index, By Packaging Type
  • 6.2. Tubes*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Bottles
  • 6.4. Syringes
  • 6.5. Flexible Pouches
  • 6.6. Ampoules
  • 6.7. Vials

7. By Application

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 7.1.2. Market Attractiveness Index, By Application
  • 7.2. Eye Drops*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Ophthalmology Gels
  • 7.4. Ophthalmology Ointment
  • 7.5. Anti-VEGF Drugs

8. By Indication

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
    • 8.1.2. Market Attractiveness Index, By Indication
  • 8.2. Refractive Errors*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Cataracts and Glaucoma
  • 8.4. Retinal Disorders
  • 8.5. Corneal Diseases
  • 8.6. Pediatric Ophthalmology
  • 8.7. Other

9. By Dosage

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Dosage
    • 9.1.2. Market Attractiveness Index, By Dosage
  • 9.2. Multi-Dose*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Single-Dose

10. By Material

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 10.1.2. Market Attractiveness Index, By Material
  • 10.2. Glass*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3. Plastic
  • 10.4. Others

11. By End User

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.1.2. Market Attractiveness Index, By End User
  • 11.2. Pharmaceutical Companies*
    • 11.2.1. Introduction
    • 11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 11.3. Medical Device Manufacturers
  • 11.4. Healthcare Providers

12. By Region

  • 12.1. Introduction
    • 12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 12.1.2. Market Attractiveness Index, By Region
  • 12.2. North America
    • 12.2.1. Introduction
    • 12.2.2. Key Region-Specific Dynamics
    • 12.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Packaging Type
    • 12.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
    • 12.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Dosage
    • 12.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 12.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 12.2.9. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 12.2.10. The U.S.
    • 12.2.11. Canada
    • 12.2.12. Mexico
  • 12.3. Europe
    • 12.3.1. Introduction
    • 12.3.2. Key Region-Specific Dynamics
    • 12.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Packaging Type
    • 12.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
    • 12.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Dosage
    • 12.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 12.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 12.3.9. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 12.3.10. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 12.3.11. Germany
    • 12.3.12. UK
    • 12.3.13. France
    • 12.3.14. Italy
    • 12.3.15. Spain
    • 12.3.16. Rest of Europe
  • 12.4. South America
    • 12.4.1. Introduction
    • 12.4.2. Key Region-Specific Dynamics
    • 12.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Packaging Type
    • 12.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
    • 12.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Dosage
    • 12.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 12.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 12.4.9. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 12.4.10. Brazil
    • 12.4.11. Argentina
    • 12.4.12. Rest of South America
  • 12.5. Asia-Pacific
    • 12.5.1. Introduction
    • 12.5.2. Key Region-Specific Dynamics
    • 12.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Packaging Type
    • 12.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
    • 12.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Dosage
    • 12.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 12.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 12.5.9. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 12.5.10. China
    • 12.5.11. India
    • 12.5.12. Japan
    • 12.5.13. South Korea
    • 12.5.14. Rest of Asia-Pacific
  • 12.6. Middle East and Africa
    • 12.6.1. Introduction
    • 12.6.2. Key Region-Specific Dynamics
    • 12.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Packaging Type
    • 12.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
    • 12.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Dosage
    • 12.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 12.6.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

13. Competitive Landscape

  • 13.1. Competitive Scenario
  • 13.2. Market Positioning/Share Analysis
  • 13.3. Mergers and Acquisitions Analysis

14. Company Profiles

  • 14.1. Amcor plc*
    • 14.1.1. Company Overview
    • 14.1.2. Product Portfolio and Description
    • 14.1.3. Financial Overview
    • 14.1.4. Key Developments
  • 14.2. West Pharmaceutical Services, Inc.
  • 14.3. Gerresheimer AG
  • 14.4. Schott AG
  • 14.5. AptarGroup, Inc.
  • 14.6. Johnson & Johnson Services, Inc.
  • 14.7. Bausch + Lomb
  • 14.8. Aerie Pharmaceuticals, Inc.
  • 14.9. Merck & Co., Inc.
  • 14.10. Akorn Operating Company LLC

LIST NOT EXHAUSTIVE

15. Appendix

  • 15.1. About Us and Services
  • 15.2. Contact Us